Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

NCT05894694 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Carcinoma

Interventions

DRUG: first-line scheme+compound kushen injection
DRUG: palliative care group first-line scheme

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences